Challenges and opportunities in the PD1/PDL1 inhibitor clinical trial landscape
Samik Upadhaya, Svetoslav T. Neftelinov, Jeffrey P. Hodge, Jay Campbell
Topics & Concepts
Clinical trialMEDLINEMedicineInternal medicinePolitical scienceLawChronic Lymphocytic Leukemia ResearchBiosimilars and Bioanalytical MethodsMonoclonal and Polyclonal Antibodies Research